Ftse Mib
33.746,66
0,00%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.454,11
-1,35%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Poolbeg Pharma Plc (POLB) Poolbeg Pharma Plc (POLB) Notizie

Poolbeg Pharma Plc

POLB
12,80
0,00 (0,00%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
01/5/202417:39ALNCNewsPoolbeg Pharma celebrates full patent approval for..
01/5/202408:00LSEG_RNSPoolbeg Pharma PLC Significant POLB 001 Patent Granted in..
30/4/202417:30ALNCNewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9..
30/4/202408:02LSEG_RNSPoolbeg Pharma PLC Appointment of Joint Broker
30/4/202408:01LSEG_RNSPoolbeg Pharma PLC Option Agreement to Acquire Orphan Drug..
30/4/202408:00LSEG_RNSPoolbeg Pharma PLC Results for the year ended 31 December..
29/4/202408:00LSEG_RNSPoolbeg Pharma PLC TR-1: Notification of major holdings
20/3/202417:18ALNCNewsEARNINGS AND TRADING: Roadside Real Estate trims Cambridge..
20/3/202408:00LSEG_RNSPoolbeg Pharma PLC POLB 001 US Patent Update
22/2/202408:00LSEG_RNSPoolbeg Pharma PLC Director/PDMR Shareholding
19/2/202414:42LSEG_RNSPoolbeg Pharma PLC Director Share Purchase
15/2/202417:02ALNCNewsTRADING UPDATES: Diversified Energy offers dividend..
15/2/202408:00LSEG_RNSPoolbeg Pharma PLC Board Role Change and Launch of EIP
12/2/202420:44ALNCNewsTRADING UPDATES: Katoro Gold launches fundraising, eyes..
12/2/202408:00LSEG_RNSPoolbeg Pharma PLC Market Opportunity for POLB 001 for CRS
17/1/202414:58ALNCNewsPoolbeg Pharma hails POLB 001'S potential to treat CRS
17/1/202408:00UKREGPoolbeg Pharma PLC Further data shows POLB001 potential in..
20/12/202321:00ALNCNewsTRADING UPDATES: K3 Business says cash balances ahead of..
20/12/202308:00UKREGPoolbeg Pharma PLC RSV AI Drug Candidate Analysis Update
11/12/202308:00UKREGPoolbeg Pharma PLC POLB 001 Data Presented at ASH
30/11/202308:00UKREGPoolbeg Pharma PLC Directorate Change
21/11/202315:39ALNCNewsTRADING UPDATES: Poolbeg hails approval; EDX links with..
21/11/202308:00RNSNONPoolbeg Pharma PLC Immunomodulator II patent granted in..
16/11/202308:00RNSNONPoolbeg Pharma PLC POLB 001 LPS Trial Data to be Presented..
09/11/202317:57ALNCNewsIN BRIEF: Poolbeg Pharma appoints former Amryt executives to..
09/11/202308:00UKREGPoolbeg Pharma PLC Former Amryt Pharma Leadership Team join..
03/11/202308:05UKREGPoolbeg Pharma PLC POLB001 Data to be Presented at ASH..
01/11/202308:00UKREGPoolbeg Pharma PLC POLB 001 Oncology Programme Update..
26/10/202308:00RNSNONPoolbeg Pharma PLC SAB Endorses Influenza Drug Targets
17/10/202311:49ALNCNewsPoolbeg Pharma shares up on metabolic drug collaboration..
17/10/202308:00UKREGPoolbeg Pharma PLC Poolbeg Partners with a Nasdaq-Listed..
02/10/202315:20ALNCNewsEARNINGS AND TRADING: Kingswood cuts outlook; Poolbeg in..
29/9/202308:00UKREGPoolbeg Pharma PLC Favourable Conclusion of Patent..
22/9/202321:37ALNCNewsTRADING UPDATES: Braemar investigation to end; Marula..
20/9/202308:00RNSNONPoolbeg Pharma PLC Immunomodulator I Patent Portfolio..
19/9/202315:42ALNCNewsTRADING UPDATES: Chill Brands unphased by regulations; Cobra..
19/9/202308:00UKREGPoolbeg Pharma PLC Immunomodulator I Patent Opposition..
13/9/202315:41ALNCNewsEARNINGS: Frontier Developments turns to loss; Poolbeg..
13/9/202308:00UKREGPoolbeg Pharma PLC Interim results for the six months to 30..
29/6/202317:52ALNCNewsPoolbeg Pharma makes "significant" influenza breakthrough..
29/6/202308:00UKREGPoolbeg Pharma PLC AI led programme identifies influenza..
22/6/202314:38ALNCNewsIN BRIEF: Poolbeg oral vaccination programme moves forward
22/6/202308:00UKREGPoolbeg Pharma PLC Oral Vaccine Programme Moves Forward
24/5/202308:00UKREGPoolbeg Pharma PLC Board Appointment
11/5/202315:27UKREGPoolbeg Pharma PLC Results of Annual General Meeting
Apertura: Min: Max:
Chiusura: 12,80

La tua Cronologia

LSE
POLB
Poolbeg Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network